China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Construction and Empirical Study of an Evaluation System for Community Volunteer Servic... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Postoperative Analgesia After Temporomandibular Joint Disc Surgery: A Prospective Rando... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Role of Vitamin D Receptor Methylation in Male Infertility among Han Males... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Mechanism of PKM2 deficiency in intestinal macrophages promoting intestinal stem cell r... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on Visual Patterns for the Early Identification of Deteriorating Conditions by ... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Trastuzumab rezetecan induction followed by dalpiciclib plus endocrine maintenance as f... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Risk Factor Analysis for Fetal Growth Restriction in Twin Pregnancies'. The following a... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Retrospective analysis based on joint prediction of pCR and long-term prognosis in brea... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Comparative Study of the Efficacy of AR Based Amblyopia Training Therapy and Occlusio... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on Immune-related Adverse Reactions Treated with adalimumab'. The following ar... Read More